Austria

AT 2007–2026
Foreign Entities
37
Filings
56
Clients
38

Foreign Entities Disclosed

Entity Name PPB Country Disclosed on filing Ownership % Year Client
MOBILKOM AUSTRIA $60,000 — 2007 MOBILKOM AUSTRIA
SUZANO INTERNATIONAL TRADE GMBH $50,000 — 2024 DCI GROUP ON BEHALF OF SUZANO
PLANSEE GROUP $30,000 100.0% 2018 GLOBAL TUNGSTEN & POWDERS
THERME GROUP RHTG AG $5,670 100.0% 2022 THERME GROUP US, LLC
PPC INSULATORS AUSTRIA GMBH $5,000 — 2020 FTI ON BEHALF OF PPC INSULATORS
AGRU KUNSTSTOFFTECHNIK GMBH — 100.0% 2017 AGRU AMERICA INC.
AMS OSRAM AG — 100.0% 2026 AMS OSRAM AG
ARTON GROUP GMBH — 100.0% 2025 ARTON CAPITAL INC.
AUSTRIAN AIRLINES — — 2018 LUFTHANSA GERMAN AIRLINES
DIGEN PHARMACEUTICALS GMBH — 100.0% 2011 HEALIANCE PHARMACEUTICALS
DIGEN PHARMACEUTICALS GMBH — 100.0% 2013 HEALIANCE PHARMACEUTICALS
DO & CO AKTIENGESELLSCHAFT — 100.0% 2020 DO & CO NEW YORK CATERING, INC.
DO & COAG — 100.0% 2021 DO & CO NEW YORK CATERING, INC.
GBS BIOVENTURES III TRUST — 21.0% 2010 CODA THERAPEUTICS, INC.
INNIO GROUP HOLDING GMBH — 100.0% 2025 INNIO WAUKESHA GAS ENGINES, INC.
INTERCELL AG United States — 100.0% 2007 INTERCELL USA INC
INTERCELL AG — 100.0% 2011 INTERCELL USA
INTERCELL, AG — 100.0% 2013 INTERCELL INC VALNEVA
ISI GROUP — 100.0% 2026 ISI NORTH AMERICA INC.
KTM AG — 100.0% 2017 KTM NORTH AMERICA, INC.
LENZING AKTIENGESELLSCHAFT — 100.0% 2012 LENZING FIBERS, INC.
LOHMANN & RAUSCHER INTERNATIONAL GMBH & CO. KG — 100.0% 2023 UNITED STATES MEDICAL COMPRESSION ALLIANCE
LOHMANN & RAUSCHER INTERNATIONAL GMBH & CO. KG — 100.0% 2023 UNITED STATES MEDICAL COMPRESSION ALLIANCE
MED-EL WORLDWIDE HEADQUARTERS — 100.0% 2010 MED-EL CORPORATION
OMV (DEBTHOLDER, 10% OF NS2 OPERATING BUDGET) — — 2017 NORD STREAM 2 AG
OMV (DEBTHOLDER, 10% OF NS2 OPERATING BUDGET) — — 2017 ROBERTI GLOBAL ON BEHALF OF NORD STREAM 2 AG
OMV AG — 10.0% 2016 NEW EUROPEAN PIPELINE AG
OSTERREICHISCHE BUNDES- UND INDUSTRIEBETEILIGUNGEN GMBH — 31.0% 2017 OMV AKTIENGESELLSCHAFT
PETER GOLDSCHEIDER — 28.0% 2023 RIVADA NETWORKS
PETER GOLDSCHEIDER — 28.0% 2023 RIVADA NETWORKS
PPC INSULATORS AUSTRIA GMBH — 100.0% 2019 PPC USA, INC.
RAHAAT AILYEV C/O DR. OTTO DIETRICH JR. — 100.0% 2008 SPEEDY FUNK FILM UND
RAHAAT AILYEV C/O DR. OTTO DIETRICH JR. — 100.0% 2008 SPEEDY FUNK FILM UND
RAHAAT AILYEV C/O DR. OTTO DIETRICH JR. — 100.0% 2008 SPEEDY FUNK FILM UND
RAHAAT AILYEV C/O DR. OTTO DIETRICH JR. — 100.0% 2008 SPEEDY FUNK FILM UND
RAIFFEISENLANDESBANK NIEDEROSTERREICH-WIEN AG — 22.0% 2020 RAIFFEISEN BANK INTERNATIONAL AG
RAIFFEISENLANDESBANK NIEDEROSTERREICH-WIEN AG — 22.0% 2019 RAIFFEISEN BANK INTERNATIONAL AG
RED BULL GMBH — — 2026 AMERICAN BEVERAGE ASSOCIATION
RED BULL GMBH — 100.0% 2023 RED BULL NORTH AMERICA, INC.
RED BULL GMBH — 100.0% 2012 RED BULL NA
RED BULL GMBH — 100.0% 2023 RED BULL NORTH AMERICA, INC.
RED BULL GMBH — 100.0% 2024 RED BULL NORTH AMERICA, INC.
RHI MAGNESITA GMBH — 100.0% 2020 MAGNESITA REFRACTORIES COMPANY
RHI MAGNESITA N.V. — 100.0% 2025 MAGNESITA REFRACTORIES COMPANY
RHI MAGNESITA N.V. — 100.0% 2025 MAGNESITA REFRACTORIES COMPANY
RIEGL LASER MEASUREMENT SYSTEMS GMBH — 100.0% 2025 RIEGL USA
ROSENBAUER INTERNATIONAL AG — 100.0% 2025 ROSENBAUER AMERICA, LLC
TEADIT INTERNATIONAL — 100.0% 2025 TEADIT GROUP
VALNEVA AUSTRIA GMBH — 100.0% 2024 VALNEVA USA, INC.
VALNEVA AUSTRIA GMBH — 100.0% 2022 VALNEVA USA, INC.
VALNEVA AUSTRIA GMBH — 100.0% 2021 VALNEVA USA, INC.
VALNEVA AUSTRIA GMBH — 100.0% 2023 VALNEVA USA, INC.
VALNEVA AUSTRIA GMBH — 100.0% 2021 VALNEVA USA, INC.
VALNEVA AUSTRIA GMBH — 100.0% 2023 VALNEVA USA, INC
VALNEVA AUSTRIA GMBH — 100.0% 2024 VALNEVA USA, INC.
VOESTALPINE AG — 49.0% 2017 VOESTALPINE AG
VOESTALPINE BAHNSYSTEME VERMOGENSVERWALTUNGS GMBH — 49.0% 2017 VOESTALPINE AG
VOESTALPINE METAL ENGINEERING GMBH & CO KG — 49.0% 2017 VOESTALPINE AG
Clients Associated
Issues Lobbied
Trade (domestic/foreign) 19 Health Issues 12 Foreign Relations 8 Tariff (miscellaneous tariff bills) 6 Defense 5 Manufacturing 5 Fuel/Gas/Oil 5 Pharmacy 5 Budget/Appropriations 4 Media (information/publishing) 4 Financial Institutions/Investments/Securities 4 Medical/Disease Research/Clinical Labs 3

Activity by Year

YearFilings
20263
20257
20244
20238
20222
20213
20204
20192
20182
20176
20161
20132
20122
20112
20102
20084
20072